Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Xiangning Liu

Showing results (81-90 of 91) with videos related to

Pageof 10
Sort By:
Journal of Medicinal Chemistry|May 14, 2026
Discovery of 1,2-Diol TRPV4 Antagonists with Efficacy in a 3D Myocardial Fibrosis Organoid Model and a Murine TAC Pressure-Overload ModelNa Chen, Ying Sun, Tingting Zhang, et al.
International Immunopharmacology|April 6, 2024
Tacrolimus alleviates pulmonary fibrosis progression through inhibiting the activation and interaction of ILC2 and monocytesBowen Liu, Qiuyan Jiang, Ruxuan Chen, et al.
Developmental Cell|March 13, 2019
The SOS2-SCaBP8 Complex Generates and Fine-Tunes an AtANN4-Dependent Calcium Signature under Salt StressLiang Ma, Jiamin Ye, Yongqing Yang, et al.
Heliyon|August 22, 2024
Isolation of anti-tumor monoclonal antibodies targeting on MICA/B α3 domain by single B cell technology for colon cancer therapyXueyi Tang, Linhai He, Xiaoli Wang, et al.
Translational Lung Cancer Research|January 24, 2022
Correlations between peripheral blood biomarkers and clinical outcomes in advanced non-small cell lung cancer patients who received immunotherapy-based treatmentsYuequan Shi, Xiaoyan Liu, Jia Liu, et al.
Nature Communications|June 4, 2021
A functional motif of long noncoding RNA Nron against osteoporosisFujun Jin, Junhui Li, Yong-Biao Zhang, et al.
Science Advances|March 13, 2026
The <i>Plasmodium falciparum</i> PPCS is a unique heteromeric complex with prokaryote-like activity and is a target of pantothenate analogsXiangning Liu, Ruitao Jin, Riyad Domingo, et al.
Nature Metabolism|September 4, 2023
ENO2-derived phosphoenolpyruvate functions as an endogenous inhibitor of HDAC1 and confers resistance to antiangiogenic therapyChenran Wang, Maohua Huang, Yuning Lin, et al.
The Journal of Clinical Investigation|August 11, 2022
Targeting FAPα-expressing hepatic stellate cells overcomes resistance to antiangiogenics in colorectal cancer liver metastasis modelsMing Qi, Shuran Fan, Maohua Huang, et al.
Thoracic Cancer|December 22, 2021
Immune checkpoint inhibitor-related adverse events in lung cancer: Real-world incidence and management practices of 1905 patients in ChinaYuequan Shi, Jian Fang, Chengzhi Zhou, et al.
Pageof 10

Showing results (81-90 of 91) with videos related to

Sort By:
Pageof 10
Journal of Medicinal Chemistry|May 14, 2026
Discovery of 1,2-Diol TRPV4 Antagonists with Efficacy in a 3D Myocardial Fibrosis Organoid Model and a Murine TAC Pressure-Overload ModelNa Chen, Ying Sun, Tingting Zhang, et al.
International Immunopharmacology|April 6, 2024
Tacrolimus alleviates pulmonary fibrosis progression through inhibiting the activation and interaction of ILC2 and monocytesBowen Liu, Qiuyan Jiang, Ruxuan Chen, et al.
Developmental Cell|March 13, 2019
The SOS2-SCaBP8 Complex Generates and Fine-Tunes an AtANN4-Dependent Calcium Signature under Salt StressLiang Ma, Jiamin Ye, Yongqing Yang, et al.
Heliyon|August 22, 2024
Isolation of anti-tumor monoclonal antibodies targeting on MICA/B α3 domain by single B cell technology for colon cancer therapyXueyi Tang, Linhai He, Xiaoli Wang, et al.
Translational Lung Cancer Research|January 24, 2022
Correlations between peripheral blood biomarkers and clinical outcomes in advanced non-small cell lung cancer patients who received immunotherapy-based treatmentsYuequan Shi, Xiaoyan Liu, Jia Liu, et al.
Nature Communications|June 4, 2021
A functional motif of long noncoding RNA Nron against osteoporosisFujun Jin, Junhui Li, Yong-Biao Zhang, et al.
Science Advances|March 13, 2026
The <i>Plasmodium falciparum</i> PPCS is a unique heteromeric complex with prokaryote-like activity and is a target of pantothenate analogsXiangning Liu, Ruitao Jin, Riyad Domingo, et al.
Nature Metabolism|September 4, 2023
ENO2-derived phosphoenolpyruvate functions as an endogenous inhibitor of HDAC1 and confers resistance to antiangiogenic therapyChenran Wang, Maohua Huang, Yuning Lin, et al.
The Journal of Clinical Investigation|August 11, 2022
Targeting FAPα-expressing hepatic stellate cells overcomes resistance to antiangiogenics in colorectal cancer liver metastasis modelsMing Qi, Shuran Fan, Maohua Huang, et al.
Thoracic Cancer|December 22, 2021
Immune checkpoint inhibitor-related adverse events in lung cancer: Real-world incidence and management practices of 1905 patients in ChinaYuequan Shi, Jian Fang, Chengzhi Zhou, et al.
Pageof 10